(Q41343312)

English

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

scientific article published on 8 April 2015

Statements

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial (English)
Masashi Mizokami
Osamu Yokosuka
Tetsuo Takehara
Masaaki Korenaga
Hitoshi Mochizuki
Kunio Nakane
Hirayuki Enomoto
Fusao Ikeda
Mikio Yanase
Takuya Genda
Takeji Umemura
Hiroshi Yatsuhashi
Tatsuya Ide
Nobuo Toda
Kazushige Nirei
Yoshiyuki Ueno
Yoichi Nishigaki
Juan Betular
Bing Gao
Akinobu Ishizaki
Masa Omote
Hongmei Mo
Kim Garrison
Phillip S Pang
Steven J Knox
William T Symonds
John G McHutchison
Masao Omata
8 April 2015
645-653

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit